Member LoginMember Login - User registration - Setup as front page - Add to favorites - Sitemap Nadal returns to Roland Garros to practice amid doubts over fitness and form !

Nadal returns to Roland Garros to practice amid doubts over fitness and form

Time:2024-05-21 14:05:25 source:Stellar Spotlight news portal

PARIS (AP) — Rafael Nadal returned to Roland Garros on Monday to practice and try and figure out whether to compete at the French Open he has won 14 times.

The 37-year-old Spaniard showed up with his coach Carlos Moya. A video on the Open’s official social media showed Nadal arriving by car.

The training was set for 5 p.m. local time (1500 GMT). It would give him a chance to reacquaint himself with Court Philippe Chatrier’s red clay — he hasn’t played a match there in two years — and test his fitness.

The tournament begins on Sunday and it remains uncertain if Nadal will enter.

He is still regaining his match readiness after missing nearly all of 2023 with a hip injury that required surgery, and much of this season because of problems with a hip muscle and an abdominal muscle.

His recent loss in the Italian Open second round ( to Hubert Hurkacz 6-1, 6-3) left Nadal unsure about whether he would consider himself ready for the French Open.

Related information
  • Here comes the char
  • Tigers hand Twins season
  • Mainland urges Taiwan to publish truth of fatal boat incident
  • House on the brink of approving Ukraine and Israel aid after long struggle
  • Company wins court ruling to continue development of Michigan factory serving EV industry
  • ADB economist lauds efforts to sustain growth
  • Taylor Swift's winning streak continues as she breaks record for most pre
  • Israel and Iran's apparent strikes give new insights into both militaries
Recommended content
  • The government wants to buy their flood
  • Marcia Clark
  • Turnbull takes no
  • William Contreras drives in 2 runs for Brewers in a 2
  • Messi in and Dybala out in Argentina squad for pre
  • Chinese researchers develop targeted nanomedicine for female Alzheimer's patients